Myelodysplastic syndrome and aplastic anemia - diagnostic and conceptual uncertainties

被引：6
|
作者：
Barrett, J [1 ]
机构：
[1] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
来源：
LEUKEMIA RESEARCH | 2000年 / 24卷 / 07期
关键词：
D O I：
10.1016/S0145-2126(00)00026-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：595 / 596
页数：2
相关论文
共 50 条
  • [41] Origins of myelodysplastic syndromes after aplastic anemia
    Negoro, Eiju
    Nagata, Yasunobu
    Clemente, Michael J.
    Hosono, Naoko
    Shen, Wenyi
    Nazha, Aziz
    Yoshizato, Tetsuichi
    Hirsch, Cassandra
    Przychodzen, Bartlomiej
    Mahfouz, Reda Z.
    Kuzmanovic, Teodora
    Sekeres, Mikkael A.
    Makishima, Hideki
    Ogawa, Seishi
    Maciejewski, Jaroslaw P.
    BLOOD, 2017, 130 (17) : 1953 - 1957
  • [42] Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: Differential diagnosis between refractory anemia and aplastic anemia
    Iwasaki, Takashi
    Murakami, Masashi
    Sugisaki, Chiho
    Sobue, Sayaka
    Ohashi, Haruhiko
    Asano, Haruhiko
    Suzuki, Motoshi
    Nakamura, Shigeo
    Ito, Masafumi
    Murate, Takashi
    PATHOLOGY INTERNATIONAL, 2008, 58 (06) : 353 - 360
  • [43] Telomere length is significantly shortened in patients with aplastic anemia compared to hypoplastic myelodysplastic syndrome
    Bouillon, A. S.
    Ferreira, M. S.
    Panse, J.
    Reinecke, P.
    Schemenau, J.
    Haas, R.
    Bruemmendorf, T. H.
    Germing, U.
    Beier, F.
    Oncology Research and Treatment, 2015, 38 : 69 - 69
  • [44] Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome
    Zhang, Mengying
    Zhang, Gaochao
    Xu, Fangfang
    Liu, Mengyuan
    Dong, Xifeng
    Qi, Weiwei
    Wang, Huaquan
    GLOBAL MEDICAL GENETICS, 2023, 10 (03): : 194 - 198
  • [45] Growth factor therapy may unmask hypoplastic myelodysplastic syndrome mimicking aplastic anemia
    Kanugo, A
    Konoplev, S
    Medeiros, LJ
    Lin, P
    LABORATORY INVESTIGATION, 2006, 86 : 232A - 232A
  • [46] High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome
    Okamoto, M
    Shichishima, T
    Noji, H
    Ikeda, K
    Nakamura, A
    Akutsu, K
    Maruyama, Y
    LEUKEMIA, 2006, 20 (04) : 627 - 634
  • [47] Updated Results of Combination Cytokine Immunotherapy In the Treatment of Aplastic Anemia and Myelodysplastic Syndrome (MDS)
    Kadia, Tapan
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Borthakur, Gautam
    Estrov, Zeev
    Pierce, Sherry A.
    York, Sergernne
    Kantarjian, Hagop M.
    BLOOD, 2010, 116 (21) : 1202 - 1203
  • [48] EVOLUTION OF ACQUIRED SEVERE APLASTIC-ANEMIA TO A MYELODYSPLASTIC SYNDROME AND ACUTE-LEUKEMIA
    GONZALEZBARCA, E
    DOMINGO, A
    DESEVILLA, AF
    GRANENA, A
    MEDICINA CLINICA, 1995, 105 (06): : 224 - 226
  • [49] Application of serum Raman spectroscopy in rapid and early discrimination of aplastic anemia and myelodysplastic syndrome
    Liang, Haoyue
    Kong, Xiaodong
    Ren, Yansong
    Wang, Haoyu
    Liu, Ertao
    Sun, Fanfan
    Zhu, Guoqing
    Zhang, Qiang
    Zhou, Yuan
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2023, 302
  • [50] Growth factor therapy may unmask hypoplastic myelodysplastic syndrome mimicking aplastic anemia
    Kanugo, A
    Konoplev, S
    Medeiros, LJ
    Lin, P
    MODERN PATHOLOGY, 2006, 19 : 232A - 232A
12345